Activation of the Tubulo-Glomerular Feedback by SGLT2 Inhibitors in Patients With Type 2 Diabetes and Advanced Chronic Kidney Disease: Toward the End of a Myth?

被引：11
|
作者：
Gerard, Alexandre O. [1 ,2 ]
Laurain, Audrey [1 ]
Favre, Guillaume [1 ]
Drici, Milou-Daniel [2 ]
Esnault, Vincent L. M. [1 ]
机构：
[1] Univ Cote Azur, Pasteur Hosp, Nephrol Dialysis Transplantat Dept, Nice, France
[2] Univ Cote Azur, Pasteur Hosp, Dept Pharmacol, Nice, France
来源：
DIABETES CARE | 2022年 / 45卷 / 10期
关键词：
D O I：
10.2337/dc22-0921
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：E148 / E149
页数：2
相关论文
共 50 条
  • [21] Expanding the Impact of SGLT2 Inhibitors in Chronic Kidney Disease
    Makawi, Alaa T.
    Tawfik, Yahya M. K.
    Dixon, Dave L.
    McMahon, Gearoid M.
    Buckley, Leo F.
    AMERICAN JOURNAL OF NEPHROLOGY, 2024, 55 (04) : 417 - 420
  • [22] SGLT2 inhibitors should be recommended in patients with one or more of the three diseases: type 2 diabetes, chronic kidney disease, and HFrEF
    Zhao, Li-Min
    Ding, Liang-Liang
    Zhan, Ze-Lin
    Qiu, Mei
    EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2021, 87 : 102 - 103
  • [23] Another Win for SGLT2 Inhibitors in Chronic Kidney Disease
    Leaf, David E.
    Bansal, Nisha
    NEW ENGLAND JOURNAL OF MEDICINE, 2025, 392 (08): : 822 - 823
  • [24] SGLT2 inhibitors : kidney as a new therapeutic target for type 2 diabetes
    Bons, Justine
    Prevost, Gaetan
    CORRESPONDANCES EN METABOLISMES HORMONES DIABETES ET NUTRITION, 2015, 19 (07): : 191 - 195
  • [25] The kidney and type 2 diabetes mellitus: therapeutic implications of SGLT2 inhibitors
    Weir, Matthew R.
    POSTGRADUATE MEDICINE, 2016, 128 (03) : 290 - 298
  • [26] SGLT2 inhibitor and incretin mimetic therapy for type 2 diabetes and chronic kidney disease
    Tuttle, Katherine R.
    LANCET DIABETES & ENDOCRINOLOGY, 2019, 7 (06): : 414 - 415
  • [27] Are SGLT2 Inhibitors Safe and Effective in Advanced Diabetic Kidney Disease?
    Zoungas, Sophia
    Polkinghorne, Kevan R.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020, 15 (12): : 1694 - 1695
  • [28] Reducing Kidney Disease Burden in Type 2 Diabetes with SGLT2 Inhibitors Shifting the Goalposts Upstream
    Rangaswami, Janani
    Mathew, Roy O.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2023, 18 (09): : 1119 - 1121
  • [29] Sodium Glucose Transport 2 (SGLT2) Inhibition Decreases Glomerular Hyperfiltration Is There a Role for SGLT2 Inhibitors in Diabetic Kidney Disease?
    Stanton, Robert C.
    CIRCULATION, 2014, 129 (05) : 542 - 544
  • [30] A cost-utility analysis of adding SGLT2 inhibitors for the management of type 2 diabetes with chronic kidney disease in Thailand
    Chitpim, Natthakan
    Leelahavarong, Pattara
    Prawjaeng, Juthamas
    Ittiphisit, Sakditat
    Srinonprasert, Varalak
    Kongmalai, Tanawan
    SCIENTIFIC REPORTS, 2025, 15 (01):
12345